AstraZeneca’s biologics research and development arm MedImmune has signed over global rights to its experimental Crohn’s disease drug MEDI2070 to Allergan, in a deal potentially worth $1.52 billion.
News
Janssen’s guselkumab beats Humira in plaque psoriasis trial
Janssen has presented Phase III data showing that its anti-interleukin (IL)-23 monoclonal antibody was superior to placebo and AbbVie’s mega-blockbuster Humira at clearing skin in patients with plaque psoriasis.
MSD, Verastem, CR UK to trial new immunotherapy combo
MSD, Verastem and Cancer Research UK are to trial a new combination of immunotherapy drugs as potential treatment for mesothelioma, non small cell lung and pancreatic cancers.
Gov’t streams £220m into commercialising innovations
The government has announced that life sciences and university sectors will receive a “package of support” including a cash stream of £220 million to help translate technology breakthroughs into commercial successes.
SBRI winners get £1m for ‘positive ageing’ products
SBRI Healthcare has unveiled the winners of its latest competition which is focused on supporting older people with complex health needs.
NHS announces new mental health pilot programme
Six pilot sites will drive the design of new mental health services for young people
Genentech in $910 million cancer licensing deal
Company buys rights to experimental pan-RAF inhibitor
NICE rejects Lilly’s Portrazza, but backs Bayer’s Xofigo and Amgen’s Imlygic
Cost regulators for the NHS in England and Wales have published final guidelines turning down the use of Eli Lilly’s Portrazza to treat lung cancer, but backing Bayer’s Xofigo for prostate cancer and Amgen’s Imlygic for melanoma.
International Clinical Researcher of the Year 2017: Stage 2 Challenges available
Competition organiser PharmaTimes Media is delighted to announce that the Stage 2 challenges are now available online for the top achievers in the MCQ.
Common painkillers could increase heart failure risk, study finds
BMJ study shows NSAIDs increase risk by 19 percent in elderly patients
Study links cancer symptom awareness with survival
Low awareness of the potential symptoms of cancer is linked to a lower chance of survival, suggests new research published in the British Journal of Cancer.
Final NICE yes for Novartis’ Cosentyx in ankylosing spondylitis
Guidelines from the National Institute for Health and Care Excellence recommend Novartis’ Cosentyx for treating active ankylosing spondylitis that has not responded well enough to conventional therapy.
South cost ambulance service placed in special measures
NHS Improvement is placing the South East Coast Ambulance Service NHS Foundation Trust into Special Measures on the back of a series of concerns that came to light in its latest Care Quality Commission (CQC) inspection report.
NHS England streams £25m into paediatric mental health
Clinical Commissioning Groups are being given an extra £25 million by NHS England to accelerate plans for improving mental health services for children and young people.
Medherant secures funds of £1.5m for transdermal patch
Coventry, UK-based University of Warwick spin-out Medherant has secured funding of £1.5 million to fuel further development of its novel drug patch delivery technology.
